Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Department of Health and Human Services National Institutes of Health
Tipo
Research/project funding
Posted on:
Scadenza delle domande:
Expired
Reference Number
PAR-22-047
The goal of this Funding Opportunity Announcement (FOA) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and behavioral symptoms.
Categories: Health.
Categories: Health.
Stati Uniti